mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015107
A cell-based cancer vaccine consisting of autologous dendritic cells (DCs) pulsed with mesothelioma tumor lysate with potential immunostimulating and antineoplastic activities. Upon administration, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount a specific cytotoxic T lymphocyte (CTL) response against mesothelioma tumor cells, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-015107 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015107",
"term": "mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine consisting of autologous dendritic cells (DCs) pulsed with mesothelioma tumor lysate with potential immunostimulating and antineoplastic activities. Upon administration, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount a specific cytotoxic T lymphocyte (CTL) response against mesothelioma tumor cells, resulting in tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mesothelioma-tumor-lysate-pulsed-autologous-dendritic-cell-vaccine/"
}
Record 10,885 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.